What's new

Human medicines European public assessment report (EPAR): Ibuprofen Gen.Orph, ibuprofen, Date of authorisation: 16/02/2024, Revision: 2, Status: Authorised

Human medicines European public assessment report (EPAR): Ibuprofen Gen.Orph, ibuprofen, Date of authorisation: 16/02/2024, Revision: 2, Status: Authorised

May 28, 2025 - 13:35
 0
Human medicines European public assessment report (EPAR): Ibuprofen Gen.Orph, ibuprofen, Date of authorisation: 16/02/2024, Revision: 2, Status: Authorised
Human medicines European public assessment report (EPAR): Ibuprofen Gen.Orph, ibuprofen, Date of authorisation: 16/02/2024, Revision: 2, Status: Authorised
Read More

Tags:

Previous Article

STAT+: CHAI’s ‘assurance lab’ effort is dead. Long live the assurance lab.

Next Article

Human medicines European public assessment report (EPAR): Lyfnua, gefapixant, Da...

Related Posts

Human medicines European public assessment report (EPAR): Brinavess, vernakalant hydrochloride, Date of authorisation: 01/09/2010, Revision: 19, Status: Authorised

Human medicines European public assessment report (EPAR...

May 19, 2025  0

Human medicines European public assessment report (EPAR): Truxima, rituximab, Date of authorisation: 17/02/2017, Revision: 24, Status: Authorised

Human medicines European public assessment report (EPAR...

May 28, 2025  0

Human medicines European public assessment report (EPAR): Neparvis, sacubitril,valsartan, Date of authorisation: 26/05/2016, Revision: 24, Status: Authorised

Human medicines European public assessment report (EPAR...

May 14, 2025  0